Skip to main content
Log in

Multi-Level Robustness Evaluation Approach: From Robustness Criterion to Adapted Algorithm of Dong

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

This paper proposes an innovative concept for robustness evaluation guided by two crucial aims: indubitable identification of the factors that significantly affect the LC method and avoidance of unnecessary time and money wasting. The first phase of the proposed strategy includes robustness screening during the method optimization. Initial assumptions of the method robustness can be tracked as the rate of the response change while the factors deviate within the expected range. Therefore, partial and total robustness criteria are calculated. If the results obtained are not satisfactory, re-optimization of the method should be considered. Otherwise, extensive robustness testing defined by experimental design and multi-level factors estimation should be performed to confirm the method robustness. Firstly, the important factors are investigated by the standard graphical (normal probability plots) and statistical (algorithm of Dong and error estimation based on a priori declared negligible effects) procedures. Since these approaches have several drawbacks, they can result in the appearance of false negative or false positive results. Thus, the modification of the statistical tests is advised in order to make the final conclusions. Special attention was dedicated to the advantages of the adapted algorithm of Dong (so-called 75 % approach) in the absence of the effect sparsity. The new approach is presented on the optimization and robustness testing of LC method for determination of ramipril and its five impurities. It is proved that the proposed strategy can perform an overall robustness estimation and successfully reveal all important factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. ICH Harmonised Tripartite Guideline, International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) (2005) Validation of analytical procedures: text and methodology Q2(R1). http://www.ich.org/LOB/media/MEDIA417.pdf

  2. Morgan E (1991) Chemometrics: experimental design, analytical chemistry by open learning. Wiley, Chichester

  3. Vander Heyden Y, Massart DL (1996) Review of the use of robustness and ruggedness in analytical chemistry. In: Hendriks MWB, De Boer JH, Smilde AK (eds) Robustness of analytical chemical methods and pharmaceutical technological products. Elsevier, Amsterdam

  4. Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vandeginste BGM, Massart DL (2001) Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed 24:723–753

    Article  CAS  Google Scholar 

  5. Malenović A, Jančić-Stojanović B, Vemić A, Ivanović D, Medenica M (2010) Validation of a column liquid chromatographic method for the analysis of pramipexole and its five impurities. J AOAC Int 93:1102–1112

    Google Scholar 

  6. Dejaegher B, Durand A, Vander Heyden Y (2009) Identification of significant effects from an experimental screening design in the absence of effect sparsity. J Chromatogr B 877:2252–2261

    Article  CAS  Google Scholar 

  7. Rakić T, Malenović A, Jančić-Stojanović B, Ivanović D, Medenica M (2012) Avoiding the false negative results in LC method robustness testing by modifications of the algorithm of Dong and dymmy factor effects approach. Chromatographia 75:397–401

    Article  Google Scholar 

  8. Vanbel PF, Tilquin BL, Schoenmakers PJ (1995) Criteria for developing rugged high-performance liquid chromatographic methods. J Chromatogr A 697:3–16

    Article  CAS  Google Scholar 

  9. De Aguiar PF, Vander Heyden Y, Massart DL (1997) Study of different criteria for the selection of a rugged optimum in high performance liquid chromatography optimization. Anal Chim Acta 348:223–235

    Article  Google Scholar 

  10. Gandhimathi M (2004) HPLC determination of losartan potassium and ramipril in tablets. Indian Drugs 41:120–122

    Google Scholar 

  11. Baing MM, Vaidya VV, Sane RT, Menon SN, Dalv K (2006) Simultaneous RP-LC determination of losartan potassium, ramipril, and hydrochlorothiazide in pharmaceutical preparations. Chromatographia 64:293–296

    Article  CAS  Google Scholar 

  12. Rao P, Kumari V, Prakash B, Prabhakar G, Begum J (2006) Determination of ramipril in pharmaceutical dosage forms by reversed-phase liquid chromatography. Asian J Chem 18:788–792

    CAS  Google Scholar 

  13. Zarapakar SS, Rane SH (2000) Reversed-phase high-performance liquid chromatographic determination of ramipril and hydrochlorothiazide in tablets. Indian Drugs 37:589–593

    CAS  Google Scholar 

  14. Dhorda UJ, Shetkar NB (1999) Reverse phase HPLC determination of ramipril and amlodipine in tablets. Indian Drugs 36:638–641

    CAS  Google Scholar 

  15. Patole SM, Potale LV, Khodke AS, Damle MC (2010) A validated HPLC method for analysis of Atorvastatin calcium, Ramipril and Aspirin as the bulk drug and in combined capsule dosage forms. Int J Pharm Sci Rew Research 4:40–45

    CAS  Google Scholar 

  16. Pachauri S, Paliwal S, Srinivas KS, Singh Y, Jain V (2010) Development and validation of HPLC method for analysis of some antihypertensive agents in their pharmaceutical dosage forms. Int J Pharm Sci Rew Research 2:459–464

    CAS  Google Scholar 

  17. Rao KS, Srinivas K (2010) RP-HPLC method for the determination of losartan potassium and ramipril in combined dosage form. Indian J Pharm Sci 72:108–111

    Article  CAS  Google Scholar 

  18. Kurade VP, Pai MG, Gude R (2009) RP-HPLC estimation of ramipril and telmisartan in tablets. Indian J Pharm Sci 71:148–151

    Article  CAS  Google Scholar 

  19. Pili NR, Imadugu JK, Mullangi R, Karra VK, Vaidya JR, Rao JVLNS (2011) Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. Biomed Chromatogr 25:439–449

    Article  Google Scholar 

  20. Gupta UK, Jain R, Lukram O, Asarwal S, Dwivedi A (2011) Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry. Talanta 83:709–716

    Article  CAS  Google Scholar 

  21. Tan A, Jin W, Deng F, Hussain S, Musuku A, Masse R (2009) Bioanalytical method development and validation using incurred samples-Simultaneous quantitation of ramipril and ramiprilat in human EDTA plasma by LC-MS/MS. J Chromatogr B 877:3673–3680

    Article  CAS  Google Scholar 

  22. Parekh SA, Pudage A, Joshi SS, Vaidya VV (2009) Simultaneous determination of simvastatin, simvastatin acid, ramipril and ramiprilate in human plasma by liquid chromatography-tandem mass spectrometry. Asian J Chem 21:3467–3479

    CAS  Google Scholar 

  23. Panchal HJ, Suhagia BN, Patel NJ, Rathod IS, Patel BH (2009) Simultaneous estimation of atorvastatin calcium, ramipril and aspirin in capsule dosage form by RP-LC. Chromatographia 69:91–95

    Article  CAS  Google Scholar 

  24. Yuan B, Wang X, Zhang F, Jia J, Tang F (2008) Simultaneous determination of ramipril and its active metabolite ramiprilat in human plasma by LC-MS-MS. Chromatographia 68:533–539

    Article  CAS  Google Scholar 

  25. Gowda KV, Mandal U, Selvan PS, Solomon WDS, Ghosh A, Sarkar AK, Agarwal S, Rao TN, Pal TK (2007) Liquid chromatography tandem mass spectrometry method for simultaneous determination of metoprolol tartrate and ramipril in human plasma. J Chromatogr B 858:13–21

    Article  CAS  Google Scholar 

  26. Lakshmi KS, Sivasubramanian L, Pal K (2010) Stability indication HPTLC method for simultaneous determination of telmisartan and ramipril in tablets. Int J Pharm Pharm Sci 2:127–129

    CAS  Google Scholar 

  27. Elshanawane AA, Mostafa SM, Elgawish MS (2008) Application of a validated, stability-indicating LC method to stress degradation studies of ramipril and moexipril.HCl. Chromatographia 67:567–573

    Article  CAS  Google Scholar 

  28. Seshadri RK, Desai MM, Raghavaraju TV, Krishnan D, Rao DV, Chakravarthy IE (2010) Simultaneous quantitative determination of metoprolol, atorvastatin and ramipril in capsules by a validated stability-indicating RP-UPLC method. Sci Pharm 78:821–834

    Article  CAS  Google Scholar 

  29. (2011) European Pharmacopoeia, (2011) European Directorate for the Quality of Medicines and HealthCare (EDQM & HealthCare), Council of Europe

  30. Jančić-Stojanović B, Popović I, Malenović A, Ivanović D, Medenica M (2010) Factorial design in optimization of chromatographic separation of ramipril and its impurities. Chromatographia 71:799–804

    Article  Google Scholar 

  31. Orlandini S, Gotti R, Giannini I, Pasquini B, Furlanetto S (2011) Development of a capillary electrophoresis method for the assay of ramipril and its impurities: an issue of cis–trans isomerization. J Chromatogr A 1218:2611–2617

    Article  CAS  Google Scholar 

  32. Goupy J (2005) What kind of experimental design for finding and checking robustness of analytical methods? Anal Chim Acta 544:184–190

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank the Ministry of Education and Science of the Republic of Serbia for supporting these investigations through the Project 172052.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Biljana Jančić-Stojanović.

Additional information

Published in the topical collection Chemometrics in Chromatography with guest editors B. Jančić-Stojanović and Y. Dotsikas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rakić, T., Vemić, S., Jančić-Stojanović, B. et al. Multi-Level Robustness Evaluation Approach: From Robustness Criterion to Adapted Algorithm of Dong. Chromatographia 76, 267–277 (2013). https://doi.org/10.1007/s10337-012-2317-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-012-2317-2

Keywords

Navigation